000			01828 a2200505 4500
005			20250515071254.0
264		0	_c20070605
008			200706s 0 0 eng d
022			_a1533-4406
024	7		_a10.1056/NEJMoa066596 _2doi
040			_aNLM _beng _cNLM
100	1		_aEnns, Gregory M
245	0	0	_aSurvival after treatment with phenylacetate and benzoate for urea-cycle disorders. _h[electronic resource]
260			_bThe New England journal of medicine _cMay 2007
300			_a2282-92 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAge Factors
650	0	4	_aAge of Onset
650	0	4	_aAmino Acid Metabolism, Inborn Errors _xblood
650	0	4	_aAmmonia _xblood
650	0	4	_aCarbamoyl-Phosphate Synthase I Deficiency Disease _xdrug therapy
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aCitrullinemia _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHyperammonemia _xdrug therapy
650	0	4	_aInfant
650	0	4	_aInfant, Newborn
650	0	4	_aMale
650	0	4	_aOrnithine Carbamoyltransferase Deficiency Disease _xdrug therapy
650	0	4	_aPhenylacetates _xadverse effects
650	0	4	_aSodium Benzoate _xadverse effects
650	0	4	_aSurvival Analysis
650	0	4	_aUrea _xmetabolism
700	1		_aBerry, Susan A
700	1		_aBerry, Gerard T
700	1		_aRhead, William J
700	1		_aBrusilow, Saul W
700	1		_aHamosh, Ada
773	0		_tThe New England journal of medicine _gvol. 356 _gno. 22 _gp. 2282-92
856	4	0	_uhttps://doi.org/10.1056/NEJMoa066596 _zAvailable from publisher's website
999			_c17078053 _d17078053